Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients-Reference-Cited by-同舟云学术

Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients

Published:2011-12-16 Issue:12 Volume:6 Page:e28951
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schmitt Jana,Keller Andreas,Nourkami-Tutdibi Nasenien,Heisel Sabrina,Habel Nunja,Leidinger Petra,Ludwig Nicole,Gessler Manfred,Graf Norbert,Berthold Frank,Lenhof Hans-Peter,Meese Eckart

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Neuroblastoma incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project.;C Spix;Eur J Cancer,2006

2. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.;GM Brodeur;J Clin Oncol,1993

3. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.;T Monclair;J Clin Oncol,2009

4. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.;SL Cohn;J Clin Oncol,2009

5. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.;GM Brodeur;Science,1984

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration;Journal for ImmunoTherapy of Cancer;2022-06

2. Systematic review of the immunological landscape of Wilms tumors;Molecular Therapy - Oncolytics;2021-09

3. Case report: value of gene expression profiling in the diagnosis of atypical neuroblastoma;BMC Research Notes;2017-08-17

4. New immunotherapeutic strategies for the treatment of neuroblastoma;Immunotherapy;2015-03

5. Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays;PLoS ONE;2013-03-04